Literature DB >> 17600643

Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes.

Bharathi Devarakonda1, Daniel P Otto, Anja Judefeind, Ronald A Hill, Melgardt M de Villiers.   

Abstract

The complexation of the practically insoluble drug furosemide (acidic pK(a) 3.22) with lower generation PAMAM dendrimers showed a significant release dependence on the ionization state of the drug. UV and FTIR studies suggested that the drug was localized in the interior of the dendrimer. The dendrimer amine, amide and ester groups, demonstrated pH-dependent ionization as did the drug carboxylic acid group and it was proven that the most efficient drug complexation was achieved in slightly acidic conditions (pH 4.0-6.0). At this pH, amide groups in the dendrimer cavities were at least partially ionized to expose a positive charge whilst the furosemide carboxylic acid ionized to great extent (pH>pK(a)) resulting in electrostatic complexation. Conversely, higher release rates were observed in acidic conditions (pH 1.2) where furosemide was virtually unionized, emphasizing the importance of the drug ionization state in the determination of drug release. Despite the complex interactions between the dendrimer and drug and its effects on release kinetics, the dendrimers resulted in higher solubility of the drug and contributed significantly to the array of available techniques to increase the solubility of poorly water-soluble drugs that are very abundant in industry today. Complexation with low generation PAMAM dendrimers (<generation 4) could provide opportunities to both increase drug solubility and tuning of the release profile for practically insoluble drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17600643     DOI: 10.1016/j.ijpharm.2007.05.039

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  Evaluation of poly(amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy.

Authors:  Magdalena Markowicz; Paweł Szymański; Marcin Ciszewski; Arkadiusz Kłys; Elżbieta Mikiciuk-Olasik
Journal:  J Biol Phys       Date:  2012-08-16       Impact factor: 1.365

2.  Enhanced photodynamic efficacy and efficient delivery of Rose Bengal using nanostructured poly(amidoamine) dendrimers: potential application in photodynamic therapy of cancer.

Authors:  Krishnamoorthy Karthikeyan; Anish Babu; Sang-Jae Kim; Ramachandran Murugesan; Kadarkaraithangam Jeyasubramanian
Journal:  Cancer Nanotechnol       Date:  2011-08-13

3.  Anti-angiogenesis effect of generation 4 polyamidoamine/vascular endothelial growth factor antisense oligodeoxynucleotide on breast cancer in vitro.

Authors:  Shan-zhi Gu; Xin-han Zhao; Ling-xiao Zhang; Li Li; Zhi-yu Wang; Min Meng; Gai-li An
Journal:  J Zhejiang Univ Sci B       Date:  2009-03       Impact factor: 3.066

4.  Bioconjugates of PAMAM dendrimers with trans-retinal, pyridoxal, and pyridoxal phosphate.

Authors:  A Filipowicz; S Wołowiec
Journal:  Int J Nanomedicine       Date:  2012-09-06

Review 5.  Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?

Authors:  Babak Kateb; Katherine Chiu; Keith L Black; Vicky Yamamoto; Bhavraj Khalsa; Julia Y Ljubimova; Hui Ding; Rameshwar Patil; Jose Antonio Portilla-Arias; Mike Modo; David F Moore; Keyvan Farahani; Michael S Okun; Neal Prakash; Josh Neman; Daniel Ahdoot; Warren Grundfest; Shouleh Nikzad; John D Heiss
Journal:  Neuroimage       Date:  2010-02-10       Impact factor: 7.400

6.  Use of Half-Generation PAMAM Dendrimers (G0.5-G3.5) with Carboxylate End-Groups to Improve the DACHPtCl2 and 5-FU Efficacy as Anticancer Drugs.

Authors:  Cláudia Camacho; Helena Tomás; João Rodrigues
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

7.  Solubility of aceclofenac in polyamidoamine dendrimer solutions.

Authors:  Jaydeep Patel; Kevin Garala; Biswajit Basu; Mihir Raval; Abhay Dharamsi
Journal:  Int J Pharm Investig       Date:  2011-07

8.  Validated reverse-phase high-performance liquid chromatography for quantification of furosemide in tablets and nanoparticles.

Authors:  Ibrahima Youm; Bi-Botti Celestin Youan
Journal:  J Anal Methods Chem       Date:  2013-09-16       Impact factor: 2.193

Review 9.  Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues.

Authors:  Kanika Madaan; Sandeep Kumar; Neelam Poonia; Viney Lather; Deepti Pandita
Journal:  J Pharm Bioallied Sci       Date:  2014-07

10.  Development and Characterization of an Amorphous Solid Dispersion of Furosemide in the Form of a Sublingual Bioadhesive Film to Enhance Bioavailability.

Authors:  Viviana De Caro; Alessia Ajovalasit; Flavia Maria Sutera; Denise Murgia; Maria Antonietta Sabatino; Clelia Dispenza
Journal:  Pharmaceutics       Date:  2017-06-24       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.